These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martínez G, Fernández A, Colom F, Martínez-Arán A, Torrent C, Group for the Study of Risperidone in Affective Disorders (GSRAD). J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872 [Abstract] [Full Text] [Related]
3. Risperidone monotherapy in manic inpatients: an open label, multicentre trial. Forsthoff A, Grunze H, Seemüller F, Stampfer R, Dittmann S, Amann B, Schmidt F, Schäfer M, Hermle L, Walden J, Schreiner A. World J Biol Psychiatry; 2007 Oct; 8(4):256-61. PubMed ID: 17853251 [Abstract] [Full Text] [Related]
7. Acute and continuation risperidone monotherapy in mania. Vieta E, Brugué E, Goikolea JM, Sánchez-Moreno J, Reinares M, Comes M, Colom F, Martínez-Arán A, Benabarre A, Torrent C. Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711 [Abstract] [Full Text] [Related]
9. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V. Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994 [Abstract] [Full Text] [Related]
15. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H. J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653 [Abstract] [Full Text] [Related]
16. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. Malempati RN, Bond DJ, Yatham LN. Int Clin Psychopharmacol; 2008 Mar; 23(2):88-94. PubMed ID: 18301123 [Abstract] [Full Text] [Related]
17. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Segal J, Berk M, Brook S. Clin Neuropharmacol; 1998 Mar; 21(3):176-80. PubMed ID: 9617509 [Abstract] [Full Text] [Related]
18. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. Pavuluri MN, Henry DB, Carbray JA, Sampson G, Naylor MW, Janicak PG. J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784 [Abstract] [Full Text] [Related]
19. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale. Lindenmayer JP, Bossie CA, Kujawa M, Zhu Y, Canuso CM. Psychopathology; 2008 Oct; 41(4):264-70. PubMed ID: 18441528 [Abstract] [Full Text] [Related]
20. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. Han C, Lee MS, Pae CU, Ko YH, Patkar AA, Jung IK. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1219-23. PubMed ID: 17532106 [Abstract] [Full Text] [Related] Page: [Next] [New Search]